Skip to content
Events

Details

Illumina will be at ESMO 2024, make sure to stop by the Illumina booth at 414, and speak with our team.​

Discover how comphrensive genomic profiling can help to inform therapy decisions and see how Illumina can support your oncology workflow from sample-to-reporting​.

We’re pleased to announce that Illumina will be hosting our workshop at ESMO 2024,  “Liquid biopsy-based biomarkers for cancer profiling and monitoring: current and future applications” on Sunday 15th September, 18:30 - 20:00pm (CET), ​ Join us for an exciting overview of the applications of liquid biopsy-based biomarkers, insights into liquid biopsy testing for colorectal cancer and more!​ For more details please click here.
Date & Time
13 Sep 2024 – 17 Sep 2024
Location
Fira Barcelona Gran Via
Spain
Europe
Topic
Oncology
This event has passed

Related Events

Nov 21
Illumina Innovation Day - RTP
21 Nov 2024
Join us as we discuss new innovative technology offerings from the Illumina product pipeline and introduce our newest system – the MiSeq i100 Series.
View Event
Dec 4
Illumina Innovation Day - Seattle
4 Dec 2024
Join us as we discuss new innovative technology offerings from the Illumina product pipeline and introduce our newest system – the MiSeq i100 Series.
View Event
Dec 5
Streamlining data analysis of genomes and exomes in oncology clinical research
5 Dec 2024
Rapid advances in genomics technologies have ushered in a new paradigm for precision medicine — especially in oncology. However, complex assays such as genomes (WGS) and exomes (WES), along with expanding biomarker knowledge and guidelines, pose challenges for labs especially with data analysis and interpretation. In this educational webinar, we overview Illumina Software solutions for trusted and streamlined oncology clinical research data analysis.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.